News | August 18, 2023
BASF, Promega and Swiss TPH collaborate to drive research for malaria control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT June 2023).
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
CiplaMed 2.0 leverages advanced analytics and automation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
